longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

KHB

002022

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -4.06, within the reasonable range, cheaper than 47.61% of the time in the past 5 years, and the industry ranks 45/85, the industry Median 11.65.

-4.06xP/E
¥5.55Stock price
¥-1.37Earnings per share
-4.06xP/E
Stock price¥5.55Earnings per share¥-1.37

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-4.14x
Typical range
-9.62x–7.07x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.65x
03774111148

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.65x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688180SHJunshi Biosciences
-75.04x92.53%¥33.08B
603392SHWantai Biological
-84.05x22.02%¥32.15B
300122SZZHIFEI-BIOL
-1.96x91.71%¥29.23B
688192SHDizal Pharmaceutical
-43.27x255.85%¥25.84B
300676SZBGI Genomics
-26.45x118.23%¥15.21B
688520SHSinocelltech
-16.78x171.21%¥15.05B
688765SHHEALTHGEN BIOTECH
-90.69x--¥12.53B
688062SHMabwell
-12.00x37.63%¥11.28B
688319SHOlymvax Biopharmaceuticals
-456.67x227.87%¥10.87B
688382SHInventisBio
-31.92x5.45%¥10.68B
300204SZStaidson BioPharm
-117.19x--¥10.53B
688105SHVazyme
-1,187.04x770.82%¥10.42B
688806SHTrinomab Pharmaceutical
-18.86x--¥9.63B
688759SHBeBetter Med
-53.37x12.50%¥9.47B
688443SHGenrix Bio
-14.46x32.19%¥8.14B
002030SZDAJY
-10.71x--¥7.31B
300294SZBOYA BIOLOGY
-114.38x281.82%¥7.03B
688177SHBIO-THERA
-14.85x2.47%¥6.82B
688276SHBCHT
-25.58x66.67%¥6.17B
688488SHAidea Pharma
-1,027.03x--¥5.95B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.